New study uses simple tests to detect hidden liver damage in rare genetic disease

NCT ID NCT04612764

First seen Apr 29, 2026 · Last updated May 07, 2026 · Updated 2 times

Summary

This study looks at whether simple, noninvasive tests like blood markers and special scans can detect liver scarring in people with urea cycle disorders. About 62 participants aged 6 to 65 will undergo these tests at five medical centers. The goal is to find better ways to monitor liver health without needing a biopsy.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ORNITHINE TRANSCARBAMYLASE DEFICIENCY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Baylor College of Medicine

    Houston, Texas, 77030, United States

  • Children's Hospital Colorado

    Aurora, Colorado, 80045, United States

  • Children's National Medical Center

    Washington D.C., District of Columbia, 20010, United States

  • Seattle Children's Hospital

    Seattle, Washington, 98105, United States

  • The Children's Hospital of Philadelphia

    Philadelphia, Pennsylvania, 19104, United States

Conditions

Explore the condition pages connected to this study.